Pharmacokinetic advantages of lipophilic statins over rosuvastatin in COVID-19 management

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan; Kaeshaelya Thiruchelvam

doi:10.1177/10815589251314193

Pharmacokinetic advantages of lipophilic statins over rosuvastatin in COVID-19 management

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan, Kaeshaelya Thiruchelvam

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	328-330
Number of pages	3
Journal	Journal of Investigative Medicine
Volume	73
Issue number	3
Early online date	6 Jan 2025
DOIs	https://doi.org/10.1177/10815589251314193
Publication status	Published - 1 Mar 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1177/10815589251314193Licence: Unspecified

Cite this

@article{5702488bcbd2402c83d19a2588fbaa1b,

title = "Pharmacokinetic advantages of lipophilic statins over rosuvastatin in COVID-19 management",

keywords = "COVID-19, Lipophilic statins, Rosuvastatin",

author = "Kow, \{Chia Siang\} and Ramachandram, \{Dinesh Sangarran\} and Hasan, \{Syed Shahzad\} and Kaeshaelya Thiruchelvam",

year = "2025",

month = mar,

day = "1",

doi = "10.1177/10815589251314193",

language = "English",

volume = "73",

pages = "328--330",

journal = "Journal of Investigative Medicine",

issn = "1081-5589",

publisher = "SAGE Publications Inc.",

number = "3",

}

TY - JOUR

T1 - Pharmacokinetic advantages of lipophilic statins over rosuvastatin in COVID-19 management

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

AU - Thiruchelvam, Kaeshaelya

PY - 2025/3/1

Y1 - 2025/3/1

KW - COVID-19

KW - Lipophilic statins

KW - Rosuvastatin

UR - https://www.scopus.com/pages/publications/105000443654

U2 - 10.1177/10815589251314193

DO - 10.1177/10815589251314193

M3 - Letter

C2 - 39760172

AN - SCOPUS:105000443654

SN - 1081-5589

VL - 73

SP - 328

EP - 330

JO - Journal of Investigative Medicine

JF - Journal of Investigative Medicine

IS - 3

ER -

Pharmacokinetic advantages of lipophilic statins over rosuvastatin in COVID-19 management

UN SDGs

Access to Document

Other files and links

Cite this